| Britney Wilkinson, CPNP | |
|
1120 15th St # Or-6000, Augusta, GA 30912-5297 | |
| (706) 726-9257 | |
| Not Available |
| Full Name | Britney Wilkinson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 1120 15th St # Or-6000, Augusta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003412248 | NPI | - | NPPES |
| 003256134A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0200X | Nurse Practitioner - Pediatrics | RN245347 (Georgia) | Primary |
| Entity Name | Au Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841230620 PECOS PAC ID: 9931013513 Enrollment ID: O20040107000188 |
News Archive
Appian Labs, LLC, a biopharmaceutical company specializing in advanced therapeutic design and delivery, has announced an exclusive Development and Commercial License Agreement for the company's AppiForm™ Modular Release System with Capsugel, the world's leading provider of dosage form solutions to the pharmaceutical and related healthcare industries. The agreement provides for Capsugel to utilize the AppiForm Modular Release System for customizable drug delivery profiles.
The Leukemia & Lymphoma Society (LLS) and Shape Pharmaceuticals announced today that they have entered into a partnership to advance Shape's novel, topical treatment for cutaneous T-Cell lymphoma (CTCL) into clinical development. The compound, SHP-141, is a first-in-class topical histone deacetylase inhibitor with the potential to treat both early- and late-stage CTCL.
Children with increased genetic risk of type 1 diabetes have different gut microbiomes than those with low risk, a new study found.
A multi-disciplinary research team at Indiana Univerity has established an association between higher industry payments to health care providers and higher medical and drug costs for patients.
› Verified 3 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
Appian Labs, LLC, a biopharmaceutical company specializing in advanced therapeutic design and delivery, has announced an exclusive Development and Commercial License Agreement for the company's AppiForm™ Modular Release System with Capsugel, the world's leading provider of dosage form solutions to the pharmaceutical and related healthcare industries. The agreement provides for Capsugel to utilize the AppiForm Modular Release System for customizable drug delivery profiles.
The Leukemia & Lymphoma Society (LLS) and Shape Pharmaceuticals announced today that they have entered into a partnership to advance Shape's novel, topical treatment for cutaneous T-Cell lymphoma (CTCL) into clinical development. The compound, SHP-141, is a first-in-class topical histone deacetylase inhibitor with the potential to treat both early- and late-stage CTCL.
Children with increased genetic risk of type 1 diabetes have different gut microbiomes than those with low risk, a new study found.
A multi-disciplinary research team at Indiana Univerity has established an association between higher industry payments to health care providers and higher medical and drug costs for patients.
› Verified 3 days ago
| Entity Name | Au Medical Associates Emergency Medicine Billing Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982089777 PECOS PAC ID: 3072823186 Enrollment ID: O20151102001458 |
News Archive
Appian Labs, LLC, a biopharmaceutical company specializing in advanced therapeutic design and delivery, has announced an exclusive Development and Commercial License Agreement for the company's AppiForm™ Modular Release System with Capsugel, the world's leading provider of dosage form solutions to the pharmaceutical and related healthcare industries. The agreement provides for Capsugel to utilize the AppiForm Modular Release System for customizable drug delivery profiles.
The Leukemia & Lymphoma Society (LLS) and Shape Pharmaceuticals announced today that they have entered into a partnership to advance Shape's novel, topical treatment for cutaneous T-Cell lymphoma (CTCL) into clinical development. The compound, SHP-141, is a first-in-class topical histone deacetylase inhibitor with the potential to treat both early- and late-stage CTCL.
Children with increased genetic risk of type 1 diabetes have different gut microbiomes than those with low risk, a new study found.
A multi-disciplinary research team at Indiana Univerity has established an association between higher industry payments to health care providers and higher medical and drug costs for patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Britney Wilkinson, CPNP Po Box 1758, Evans, GA 30809-1758 Ph: (706) 854-2500 | Britney Wilkinson, CPNP 1120 15th St # Or-6000, Augusta, GA 30912-5297 Ph: (706) 726-9257 |
News Archive
Appian Labs, LLC, a biopharmaceutical company specializing in advanced therapeutic design and delivery, has announced an exclusive Development and Commercial License Agreement for the company's AppiForm™ Modular Release System with Capsugel, the world's leading provider of dosage form solutions to the pharmaceutical and related healthcare industries. The agreement provides for Capsugel to utilize the AppiForm Modular Release System for customizable drug delivery profiles.
The Leukemia & Lymphoma Society (LLS) and Shape Pharmaceuticals announced today that they have entered into a partnership to advance Shape's novel, topical treatment for cutaneous T-Cell lymphoma (CTCL) into clinical development. The compound, SHP-141, is a first-in-class topical histone deacetylase inhibitor with the potential to treat both early- and late-stage CTCL.
Children with increased genetic risk of type 1 diabetes have different gut microbiomes than those with low risk, a new study found.
A multi-disciplinary research team at Indiana Univerity has established an association between higher industry payments to health care providers and higher medical and drug costs for patients.
› Verified 3 days ago
Mr. Robert Scott Smith, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8549 | |
Veronica Bradford, APRN Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 2467 Golden Camp Rd, Augusta, GA 30906 Phone: 706-790-4440 | |
Nadia Reese, AGACNP-BC, RN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3604 Wheeler Rd Ste E, Augusta, GA 30909 Phone: 706-432-1111 | |
Kristin Anderson Hannah, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3651 Wheeler Rd, Augusta, GA 30909 Phone: 706-863-9595 Fax: 706-868-8735 | |
Magen Brooke Luke, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3675 J Dewey Gray Cir Ste 300, Augusta, GA 30909 Phone: 706-863-9595 Fax: 706-868-8375 | |
Dr. Suzanne Dixson Thomas, APRN-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1916 N Leg Rd, Family Health Coordinator, East Central Health District, Augusta, GA 30909 Phone: 706-667-4285 Fax: 706-667-4607 |